<DOC>
	<DOCNO>NCT02243514</DOCNO>
	<brief_summary>Sympathetic hyperactivity causal promote factor many disease , condition , morphology change due hyperactivity occur . Renal nerve important part autonomic nervous system regulation , especially cardiovascular system , modulation renal nerve use therapeutic strategy research across world . The purpose study evaluate quantify morphology change different disease , make modulation therapy selective effective .</brief_summary>
	<brief_title>Intravascular Ultrasound Evaluation Renal Nerves Different Diseases</brief_title>
	<detailed_description>People eligible study divide 4 group accord eligibility criterion ( Resistant Hypertension Group , Essential Hypertension Group , Chronic Heart Failure Group Control Group ) , 15 object , totally 60 object go recruit . Before intravascular ultrasound examination , ambulatory blood pressure , ECG , plasma catecholamine hormone , renin-angiotension-aldosterone , ect . measure . An intravascular ultrasound examination take do .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Resistant hypertension group blood pressure remain goal spite concurrent use three antihypertensive agent ( include diuretic ) adequate dos . agrees study procedure ( ) perform additional procedure evaluation 2 . Essential hypertension group systolic blood pressure ≥ 140 mmHg , diastolic blood pressure ≥ 90 mmHg , current use antihypertensive medication normal blood pressure mean ambulatory blood pressure 24hour≥130/80 mmHg . resistant pharmacotherapy . agree study procedure ( ) perform additional procedure evaluation 3 . Chronic heart failure group New York Heart Association class IIIII symptom , American College Cardiology ( ACC ) / American Heart Association ( AHA ) heart failure classification BC class chronic heart failure . currently prior sign heart failure , elevate jugular venous pressure , peripheral edema , pulmonary crepitation , ect . Systolic leave ventricular dysfunction assess echocardiogram leave ventricular ejection fraction &lt; 40 % . agree study procedure ( ) perform additional procedure evaluation 4 . Control group history arterial hypertension , heart failure diabetes go take vascular interventional examination hospitalization agree study procedure ( ) perform additional procedure evaluation All patient full capacity civil conduct agree sign Medical Informed Consent . hemodynamically anatomically significant renal artery stenosis . renal artery variation . renal artery diameter &lt; 4 mm , trunk length &lt; 20 mm . secondary hypertension know cause pseudohypertension . experienced myocardial infarction , unstable angina pectoris , cerebrovascular accident within 6 month . implantable cardioverter defibrillator ( ICD ) pacemaker . require respiratory support . pregnant planning pregnant . cardiovascular disease sever hemodynamic disorder . type 1 diabetes mellitus . currently enrol another investigational drug device trial . civil disability limit capacity civil conduct . condition researcher consider unsuitable enrolled trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Sympathetic hyperactivity</keyword>
	<keyword>Renal nerve</keyword>
	<keyword>Remodeling</keyword>
	<keyword>Nerve remodel</keyword>
</DOC>